Clinical trial
A Clinical Study Of An Investigational Regimen Including Marketed HIV Drugs In…
NCT00040664 · ViiV Healthcare, Industry · Completed
Key facts
| NCT number | NCT00040664 |
|---|---|
| Title | A Clinical Study Of An Investigational Regimen Including Marketed HIV Drugs In HIV-1 Pediatric Subjects Ages 2-18 Years |
| Official title | A 48 Week, Phase II, Open-Label Multi-Cohort, Multicenter Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Antiviral Activity of GW433908/Ritonavir QD and GW433908/Ritonavir BID When Administered to HIV-1 Infected, Antiretroviral Naive and Experienced, Pediatric Subjects 2-18 Years… |
| Lead sponsor | ViiV Healthcare, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | HIV Infection |
| Intervention type | Drug |
| Interventions | ritonavir, fosamprenavir |
| Enrollment | 69 |
| Start date | Jul 1, 2002 |
| Primary completion | Oct 1, 2008 |
| Completion | Oct 1, 2008 |
| First posted | Jul 10, 2002 |
| Last update posted | Mar 3, 2017 |
| Countries | Canada, Italy, Netherlands, Portugal, Romania, Spain, United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: